Form 4: Quaker Chemical Director Fay West Reports Vesting of Restricted Stock Units and New Equity Grant

Quaker Chemical Corp. Director Fay West reported the vesting and conversion of 716 restricted stock units and 9 dividend equivalent rights into common stock, alongside a new grant of 1,198 restricted stock units as part of her 2025 compensation.

Summary

• Fay West, a Director at Quaker Chemical Corp. (KWR), reported transactions on May 31, 2025, and June 1, 2025.
• On May 31, 2025, 716 restricted stock units (RSUs) and 9 dividend equivalent rights (DERs) vested and converted into 725 shares of KWR common stock.
• These RSUs were originally granted on June 1, 2024, and vested 100% on May 31, 2025.
• The DERs accrued as dividends were paid on KWR common stock, with each right being the economic equivalent of one share.
• Following these transactions, Fay West directly beneficially owns 4,063 shares of Common Stock.
• Additionally, 2,492 shares are indirectly beneficially owned by The Douglas West Revocable Trust.
• On June 1, 2025, Ms. West was granted 1,198 new time-based restricted stock units under the Company's Long-Term Performance Incentive Plan as part of her 2025 non-executive director compensation.
• These new RSUs are scheduled to vest 100% on May 31, 2026, and will also accrue dividend equivalent rights.

Sentiment

Score: 7

Explanation: The document reports routine, positive equity compensation events for a director, indicating continued alignment of interests and standard corporate governance practices. There are no negative or unexpected elements.

Positives

• Director Fay West's equity stake in Quaker Chemical Corp. increased through the vesting and conversion of restricted stock units and dividend equivalent rights, aligning her interests with shareholders.
• The grant of 1,198 new restricted stock units demonstrates ongoing compensation and commitment to the director, further aligning long-term interests.

Negatives

• No explicit negatives are present in this Form 4 filing, as it primarily reports routine compensation-related equity transactions.

Future Outlook

The filing indicates that 1,198 newly granted restricted stock units are scheduled to vest 100% on May 31, 2026, and will accrue dividend equivalent rights until that time.

Industry Context

This Form 4 filing reflects routine equity compensation practices for non-executive directors in publicly traded companies, where a portion of compensation is often granted in the form of restricted stock units to align director interests with long-term shareholder value. Such grants are common across various industries, including specialty chemicals, where Quaker Chemical operates.

Comparison to Industry Standards

• The compensation structure involving restricted stock units with vesting periods and dividend equivalent rights is a standard practice for non-executive directors in U.S. public companies.
• While specific comparable companies or projects are not detailed in this filing, this type of equity grant is consistent with corporate governance best practices aimed at fostering long-term alignment between directors and shareholder interests, similar to practices observed at peers in the specialty chemicals sector like PPG Industries, Sherwin-Williams, or RPM International, which also utilize equity-based compensation for their boards.

Corporate Governance

Related Party Transactions

• The transactions involve equity compensation granted by Quaker Chemical Corp. to Fay West, a director, which is a standard related-party transaction in the context of executive and director compensation.
• Indirect beneficial ownership of 2,492 shares by The Douglas West Revocable Trust, which is likely a related entity to Fay West.

Stakeholder Impact

• Shareholders: The increase in director equity ownership through compensation aligns the director's interests with long-term shareholder value. The transparency of these transactions through Form 4 filings provides investors with insight into insider holdings.
• Employees: No direct impact on general employees is indicated by this filing, which focuses on director compensation.
• Management: The compensation structure for non-executive directors, as evidenced by this grant, reflects the company's approach to attracting and retaining qualified board members.

Next Steps

• The 1,198 restricted stock units granted on June 1, 2025, are expected to vest 100% on May 31, 2026.
• Dividend equivalent rights will continue to accrue on the newly granted restricted stock units until their vesting date.

Key Dates

Recommendation

Keywords

Quaker Chemical Corp, KWR, SEC Form 4, Insider Trading, Director Compensation, Restricted Stock Units, Equity Grant, Beneficial Ownership, Dividend Equivalent Rights, Executive Compensation